Keyword Analysis & Research: lutathera


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
lutathera1.520.32880939

Keyword Research: People who searched lutathera also searched

Keyword CPC PCC Volume Score
lutathera1.680.189591

Search Results related to lutathera on Search Engine

  • LUTATHERA® (lutetium Lu 177 dotatate) | GEP-NET Treatment

    lutathera.com

    https://us.lutathera.com/

    WebApproved Use. What is LUTATHERA? LUTATHERA ® (lutetium Lu 177 dotatate) is a prescription medicine used to treat adults with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive... Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USE.

    DA: 39 PA: 54 MOZ Rank: 19

  • Novartis radioligand therapy Lutathera® FDA approved as first …

    novartis.com

    https://www.novartis.com/news/media-releases/novartis-radioligand-therapy-lutathera-fda-approved-first-medicine-specifically-pediatric-patients-gastroenteropancreatic-neuroendocrine-tumors

    Web2 days ago · This approval makes Lutathera the first therapy specifically reviewed and approved for use in pediatric patients with GEP-NETs. “Lutathera is now the very first therapy approved specifically for children with GEP-NETs, offering new hope to young patients living with this rare cancer,” said Tina Deignan, Therapeutic Area Head, …

    DA: 86 PA: 27 MOZ Rank: 38

  • Novartis radioligand therapy Lutathera® FDA approved as first …

    yahoo.com

    https://finance.yahoo.com/news/novartis-radioligand-therapy-lutathera-fda-175600181.html

    Web1 day ago · The approval was based on the NETTER-P trial, which evaluated Lutathera in patients aged 12 to <18 years old with SSTR+ GEP-NETs 7.The study reported a safety profile consistent with the adult ...

    DA: 8 PA: 97 MOZ Rank: 80

  • Lutathera Uses, Side Effects & Warnings - Drugs.com

    drugs.com

    https://www.drugs.com/mtm/lutathera.html

    WebMay 1, 2023 · Lutathera is a radioactive medicine that binds itself to a specific part of certain tumor cells, allowing the radiation to enter and destroy those cells. Lutathera is used to treat certain cancers of the digestive tract, including the stomach, pancreas, and intestines. Lutathera may also be used for purposes not listed in this medication guide.

    DA: 3 PA: 11 MOZ Rank: 33

  • Novartis radioligand therapy Lutathera® FDA approved as

    biospace.com

    https://www.biospace.com/article/releases/novartis-radioligand-therapy-lutathera-fda-approved-as-first-medicine-specifically-for-pediatric-patients-with-gastroenteropancreatic-neuroendocrine-tumors/

    Web1 day ago · What is Lutathera? LUTATHERA is a prescription medicine used to treat adult and pediatric patients 12 years and older with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin, including GEP-NETs in the foregut, midgut, and hindgut.

    DA: 7 PA: 13 MOZ Rank: 74


  • Lutathera Delays Growth of Advanced Neuroendocrine Tumors

    cancer.gov

    https://www.cancer.gov/news-events/cancer-currents-blog/2024/lutathera-neuroendocrine-tumor-initial-treatment

    WebMar 1, 2024 · Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine Tumors. Subscribe. March 1, 2024 , by Shana Spindler. Lu 177-dotatate (pink and orange) binds to somatostatin receptors (green) on neuroendocrine tumor cells (blue) and kills the cells through the release of radioactive particles. Credit: Adapted from Frontiers in …

    DA: 17 PA: 96 MOZ Rank: 64

  • About Your Lutathera® Treatment - Memorial Sloan Kettering Cancer Center

    mskcc.org

    https://www.mskcc.org/cancer-care/patient-education/about-your-lutathera-treatment

    WebSep 28, 2022 · Lutathera is a medication used to treat neuroendocrine tumors. It can help make the tumors grow more slowly or stop them from growing. It can also help manage symptoms caused by the tumors. Lutathera is a radioactive targeted therapy. It has 2 main parts: a tumor-targeted and a radioactive part.

    DA: 85 PA: 65 MOZ Rank: 84

  • GEP-NETs Treatment | LUTATHERA® (lutetium Lu 177 dotatate)

    lutathera-hcp.com

    https://www.lutathera-hcp.com/

    WebLUTATHERA® (lutetium Lu 177 dotatate) is indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut... Click or scroll to see IMPORTANT SAFETY INFORMATION AND INDICATION. GEP-NETs, gastroenteropancreatic neuroendocrine tumors. …

    DA: 97 PA: 2 MOZ Rank: 19

  • LUTATHERA® (lutetium Lu 177 dotatate) Treatment Journey

    lutathera.com

    https://us.lutathera.com/about-lutathera/understanding-your-treatment-journey

    WebLUTATHERA® (lutetium Lu 177 dotatate) Treatment Journey. Patients HCP. This site is for US residents only. Prescribing Information. Understanding Your Treatment Journey. Ask your doctor if they have heard the latest on LUTATHERA. LUTATHERA has been studied in more people. If you are an HCP, you can follow the link below to see the data.

    DA: 72 PA: 71 MOZ Rank: 36

  • Lutetium (177Lu) oxodotreotide - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Lutetium_(177Lu)_oxodotreotide

    WebLutetium (177Lu) oxodotreotide ( INN) or 177Lu DOTA-TATE, trade name Lutathera, is a chelated complex of a radioisotope of the element lutetium with DOTA-TATE, used in peptide receptor radionuclide therapy (PRRT). Specifically, it is used in the treatment of cancers which express somatostatin receptors. [5]

    DA: 92 PA: 67 MOZ Rank: 34